BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24879114)

  • 1. Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: a genome-wide follow-up study.
    Medina-Martinez I; Barrón V; Roman-Bassaure E; Juárez-Torres E; Guardado-Estrada M; Espinosa AM; Bermudez M; Fernández F; Venegas-Vega C; Orozco L; Zenteno E; Kofman S; Berumen J
    PLoS One; 2014; 9(5):e97842. PubMed ID: 24879114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines.
    Vazquez-Mena O; Medina-Martinez I; Juárez-Torres E; Barrón V; Espinosa A; Villegas-Sepulveda N; Gómez-Laguna L; Nieto-Martínez K; Orozco L; Roman-Basaure E; Muñoz Cortez S; Borges Ibañez M; Venegas-Vega C; Guardado-Estrada M; Rangel-López A; Kofman S; Berumen J
    PLoS One; 2012; 7(3):e32667. PubMed ID: 22412903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer.
    Wilting SM; de Wilde J; Meijer CJ; Berkhof J; Yi Y; van Wieringen WN; Braakhuis BJ; Meijer GA; Ylstra B; Snijders PJ; Steenbergen RD
    Genes Chromosomes Cancer; 2008 Oct; 47(10):890-905. PubMed ID: 18618715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer.
    Mine KL; Shulzhenko N; Yambartsev A; Rochman M; Sanson GF; Lando M; Varma S; Skinner J; Volfovsky N; Deng T; Brenna SM; Carvalho CR; Ribalta JC; Bustin M; Matzinger P; Silva ID; Lyng H; Gerbase-DeLima M; Morgun A
    Nat Commun; 2013; 4():1806. PubMed ID: 23651994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma.
    Rao PH; Arias-Pulido H; Lu XY; Harris CP; Vargas H; Zhang FF; Narayan G; Schneider A; Terry MB; Murty VV
    BMC Cancer; 2004 Feb; 4():5. PubMed ID: 15018632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer.
    Lando M; Holden M; Bergersen LC; Svendsrud DH; Stokke T; Sundfør K; Glad IK; Kristensen GB; Lyng H
    PLoS Genet; 2009 Nov; 5(11):e1000719. PubMed ID: 19911042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.
    Scotto L; Narayan G; Nandula SV; Arias-Pulido H; Subramaniyam S; Schneider A; Kaufmann AM; Wright JD; Pothuri B; Mansukhani M; Murty VV
    Genes Chromosomes Cancer; 2008 Sep; 47(9):755-65. PubMed ID: 18506748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.
    Kuglik P; Smetana J; Vallova V; Moukova L; Kasikova K; Cvanova M; Brozova L
    Int J Clin Exp Pathol; 2014; 7(8):5071-82. PubMed ID: 25197380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.
    Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y
    FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
    Samur MK; Shah PK; Wang X; Minvielle S; Magrangeas F; Avet-Loiseau H; Munshi NC; Li C
    BMC Genomics; 2013 Oct; 14():672. PubMed ID: 24088394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
    Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
    J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines.
    Lockwood WW; Coe BP; Williams AC; MacAulay C; Lam WL
    Int J Cancer; 2007 Jan; 120(2):436-43. PubMed ID: 17096350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of HPV-mediated immune alterations in cervical cancer.
    Chen L; Luan S; Xia B; Liu Y; Gao Y; Yu H; Mu Q; Zhang P; Zhang W; Zhang S; Wei G; Yang M; Li K
    Gynecol Oncol; 2018 May; 149(2):248-255. PubMed ID: 29572030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.
    Lando M; Fjeldbo CS; Wilting SM; C Snoek B; Aarnes EK; Forsberg MF; Kristensen GB; Steenbergen RD; Lyng H
    Epigenetics; 2015; 10(10):970-80. PubMed ID: 26291246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1.
    Xu J; Liu H; Yang Y; Wang X; Liu P; Li Y; Meyers C; Banerjee NS; Wang HK; Cam M; Lu W; Chow LT; Xie X; Zhu J; Zheng ZM
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network model of a cooperative genetic landscape in brain tumors.
    Bredel M; Scholtens DM; Harsh GR; Bredel C; Chandler JP; Renfrow JJ; Yadav AK; Vogel H; Scheck AC; Tibshirani R; Sikic BI
    JAMA; 2009 Jul; 302(3):261-75. PubMed ID: 19602686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis.
    Dittmann J; Ziegfeld A; Jansen L; Gajda M; Kloten V; Dahl E; Runnebaum IB; Dürst M; Backsch C
    Mol Carcinog; 2017 Jun; 56(6):1578-1589. PubMed ID: 28059468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of Human Papillomavirus Type 16 Genetic and Epigenetic Profiles in Cervical Cancer Patients Is Indicative of Poor Disease Prognosis: A Cohort Analysis.
    Dutta S; Singh RK; Mandal RK; Roychoudhury S; Basu P; Panda CK
    Int J Gynecol Cancer; 2016 May; 26(4):750-7. PubMed ID: 27051049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.